MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
NASDAQ:MDXG
Price:
4.38
USD
Market Closed
Market Cap:
$648.7m
Balance Sheet
Balance Sheet Decomposition
MiMedx Group Inc
MiMedx Group Inc
Balance Sheet Decomposition is not available for
MiMedx Group Inc
MiMedx Group Inc
Balance Sheet
MiMedx Group Inc
MiMedx Group Inc
Currency: USD
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
3
|
1
|
4
|
7
|
44
|
47
|
29
|
34
|
28
|
45
|
69
|
96
|
87
|
66
|
82
|
104
|
166
|
|
| Cash Equivalents |
3
|
1
|
4
|
7
|
44
|
47
|
29
|
34
|
28
|
45
|
69
|
96
|
87
|
66
|
82
|
104
|
166
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
2
|
8
|
16
|
27
|
54
|
67
|
1
|
1
|
32
|
46
|
41
|
44
|
54
|
56
|
76
|
|
| Accounts Receivables |
0
|
0
|
2
|
8
|
16
|
27
|
54
|
67
|
0
|
0
|
32
|
35
|
40
|
43
|
54
|
56
|
76
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
1
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
1
|
3
|
4
|
5
|
8
|
18
|
10
|
16
|
9
|
10
|
11
|
13
|
21
|
24
|
25
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
2
|
4
|
7
|
11
|
13
|
13
|
9
|
9
|
11
|
7
|
8
|
10
|
|
| Total Current Assets |
3
|
2
|
7
|
18
|
65
|
86
|
96
|
127
|
49
|
74
|
123
|
161
|
149
|
134
|
164
|
192
|
277
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
4
|
5
|
10
|
14
|
14
|
17
|
16
|
15
|
14
|
11
|
9
|
12
|
5
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
4
|
5
|
10
|
14
|
14
|
17
|
16
|
15
|
14
|
11
|
9
|
12
|
5
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
4
|
5
|
9
|
13
|
19
|
24
|
30
|
33
|
36
|
20
|
21
|
23
|
|
| Intangible Assets |
5
|
4
|
15
|
12
|
11
|
11
|
11
|
23
|
10
|
10
|
8
|
6
|
5
|
6
|
5
|
12
|
14
|
|
| Goodwill |
1
|
1
|
4
|
4
|
4
|
4
|
4
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
19
|
19
|
19
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
15
|
10
|
28
|
2
|
0
|
0
|
0
|
0
|
41
|
29
|
27
|
|
| Other Assets |
1
|
1
|
4
|
4
|
4
|
4
|
4
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
19
|
19
|
19
|
|
| Total Assets |
10
N/A
|
7
-24%
|
27
+266%
|
35
+30%
|
85
+141%
|
109
+29%
|
136
+24%
|
193
+42%
|
121
-37%
|
123
+1%
|
167
+36%
|
202
+21%
|
188
-7%
|
171
-9%
|
239
+39%
|
264
+10%
|
343
+30%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
3
|
4
|
7
|
11
|
9
|
15
|
9
|
9
|
7
|
9
|
9
|
7
|
15
|
|
| Accrued Liabilities |
0
|
0
|
1
|
4
|
7
|
14
|
20
|
23
|
37
|
55
|
55
|
50
|
35
|
34
|
33
|
34
|
42
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
16
|
1
|
2
|
0
|
0
|
0
|
0
|
3
|
3
|
6
|
|
| Total Current Liabilities |
1
|
1
|
5
|
5
|
10
|
18
|
27
|
51
|
46
|
72
|
67
|
59
|
42
|
44
|
46
|
46
|
64
|
|
| Long-Term Debt |
3
|
0
|
3
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
62
|
48
|
48
|
49
|
48
|
18
|
16
|
|
| Other Liabilities |
0
|
0
|
8
|
6
|
2
|
2
|
1
|
10
|
2
|
2
|
4
|
4
|
5
|
5
|
2
|
7
|
5
|
|
| Total Liabilities |
4
N/A
|
1
-64%
|
15
+1 069%
|
15
N/A
|
11
-27%
|
20
+79%
|
28
+40%
|
60
+116%
|
48
-21%
|
73
+54%
|
133
+81%
|
111
-17%
|
95
-14%
|
97
+2%
|
96
-1%
|
71
-26%
|
86
+22%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
92
|
93
|
93
|
0
|
0
|
0
|
|
| Retained Earnings |
40
|
52
|
62
|
70
|
74
|
68
|
38
|
26
|
47
|
77
|
102
|
151
|
162
|
192
|
134
|
91
|
43
|
|
| Additional Paid In Capital |
47
|
58
|
74
|
90
|
147
|
162
|
163
|
161
|
165
|
165
|
147
|
159
|
166
|
174
|
276
|
284
|
299
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
6
|
17
|
2
|
44
|
39
|
11
|
7
|
4
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
6
N/A
|
12
+95%
|
20
+68%
|
74
+268%
|
89
+21%
|
108
+21%
|
133
+23%
|
74
-45%
|
50
-33%
|
34
-31%
|
91
+166%
|
93
+1%
|
75
-20%
|
143
+92%
|
193
+35%
|
257
+33%
|
|
| Total Liabilities & Equity |
10
N/A
|
7
-24%
|
27
+266%
|
35
+30%
|
85
+141%
|
109
+29%
|
136
+24%
|
193
+42%
|
121
-37%
|
123
+1%
|
167
+36%
|
202
+21%
|
188
-7%
|
171
-9%
|
239
+39%
|
264
+10%
|
343
+30%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
50
|
64
|
74
|
88
|
104
|
108
|
107
|
110
|
109
|
109
|
111
|
111
|
112
|
114
|
146
|
147
|
148
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
